← Leaderboards
John J Reilly
Brigham And Women'S Hospital
$8,979,111
Attributed
$8,979,111
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$8,979,111 · 8
By mechanism
R01$4,290,695 · 2
U10$2,958,501 · 1
T32$1,084,622 · 1
P50$451,890 · 1
N01$149,854 · 1
M01$43,549 · 2
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Edwin K Silverman$89,199,838
- Elliot Israel$35,880,602
- Edward P Ingenito$10,382,683
- George R Washko$16,445,968
- Craig P Hersh$16,648,360
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchChronic Obstructive Pulmonary DiseasePatient Oriented ResearchRespiratory Disorder DiagnosisDiagnosis Design /EvaluationFunctional /Structural GenomicsInhibitor /AntagonistBiomarkerLungOutcomes ResearchHuman Therapy EvaluationPatient /Disease RegistryGenetic PolymorphismCooperative StudyDisease /Disorder Prevention /ControlGenetic SusceptibilityCellsCause Of DeathBiomedical FacilityCancer TherapyCollagenCancer PatientAsthma
Grant awards (18)
The Emphysematous Microenvironment Promotes Lung Tumorigenesis and Progression$649,363
R01 · FY2013 · HL · contact PI
The Emphysematous Microenvironment Promotes Lung Tumorigenesis and Progression$712,065
R01 · FY2012 · HL · contact PI
The Emphysematous Microenvironment Promotes Lung Tumorigenesis and Progression$700,893
R01 · FY2011 · HL · contact PI
MACROLIDES AND COPD EXACERBATIONS$5,654
M01 · FY2008 · RR · contact PI
Integrated Training in Respiratory Research$542,311
T32 · FY2007 · HL · contact PI
MACROLIDES AND COPD EXACERBATIONS$37,895
M01 · FY2007 · RR · contact PI
COPD Exacerbations: Pharmacogenetic Approaches to Thera*$569,356
U10 · FY2006 · HL · contact PI
Integrated Training in Respiratory Research$542,311
T32 · FY2006 · HL · contact PI
COPD Exacerbations: Pharmacogenetic Approaches to Thera*$651,517
U10 · FY2005 · HL
Functional Genomic Biomarkers in COPD$573,557
R01 · FY2005 · HL
COPD Exacerbations: Pharmacogenetic Approaches to Thera*$790,394
U10 · FY2004 · HL
Functional Genomic Biomarkers in COPD$553,177
R01 · FY2004 · HL
COPD Exacerbations: Pharmacogenetic Approaches to Thera*$947,234
U10 · FY2003 · HL
Functional Genomic Biomarkers in COPD$532,761
R01 · FY2003 · HL
Functional Genomic Biomarkers in COPD$568,879
R01 · FY2002 · HL
CORE--PATIENT RESOURCE$225,945
P50 · FY2001 · HL
CORE--PATIENT RESOURCE$225,945
P50 · FY2000 · HL
CLNICAL CENTER FOR THE LVRS$149,854
N01 · FY2000 · HR